Sam E. Scanga
Impact in
-
- Renin-Angiotensin System Studies
- Cardiac Fibrosis and Remodeling
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Developmental Biology and Gene Regulation 3
- Wnt/β-catenin signaling in development and cancer 1
- PI3K/AKT/mTOR signaling in cancer 1
- Protein Degradation and Inhibitors 1
- Genetics 1
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Armen S. Manoukian (5 shared papers)Mark C. Chappell (1 shared paper)Chana Yagil (1 shared paper)Renu Sarao (1 shared paper)Peter H. Backx (1 shared paper)I. Kozieradzki (1 shared paper)Antonio Oliveira-dos-Santos (1 shared paper)Carlos Maria Ferrario (1 shared paper)
- Journals
- Blood (2 papers)Nature (1 paper)Genome (1 paper)Journal of Experimental Zoology (1 paper)Oncogene (1 paper)
- Partner nations
- CanadaUnited StatesIsrael
In The Last Decade
Sam E. Scanga
7 papers receiving 1.6k citations
Sam E. Scanga's Hit Papers
Peers
Comparison fields: 5 of 76
- Cardiology and Cardiovascular Medicine 936
- Infectious Diseases 430
- Aging 12
- Nephrology 57
- Molecular Biology 211
Countries citing papers authored by Sam E. Scanga
This map shows the geographic impact of Sam E. Scanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam E. Scanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam E. Scanga more than expected).
Fields of papers citing papers by Sam E. Scanga
This network shows the impact of papers produced by Sam E. Scanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam E. Scanga. The network helps show where Sam E. Scanga may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam E. Scanga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin-converting enzyme 2 is an essential regulator of heart function Hit paper breakdown → | 2002 | 1478 |
| 2 | 2000 | 157 | |
| 3 | 1993 | 39 | |
| 4 | 1998 | 10 | |
| 5 | 1995 | 8 | |
| 6 | 2004 | 4 | |
| 7 | 2012 | 3 |
About Sam E. Scanga
Sam E. Scanga is a scholar working on Molecular Biology, Genetics, Hematology, Cardiology and Cardiovascular Medicine and Nuclear Energy and Engineering, having authored 7 papers that have together received 1.7k indexed citations. Recurring topics across this work include Developmental Biology and Gene Regulation (3 papers), Wnt/β-catenin signaling in development and cancer (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Renin-Angiotensin System Studies (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (936 citations), Infectious Diseases (430 citations), Aging (12 citations), Nephrology (57 citations) and Molecular Biology (211 citations). Sam E. Scanga has collaborated with scholars based in Canada, United States and Israel. Frequent co-authors include Armen S. Manoukian, Mark C. Chappell, Chana Yagil, Renu Sarao, Peter H. Backx, I. Kozieradzki, Antonio Oliveira-dos-Santos, Carlos Maria Ferrario, Gavin Y. Oudit and James William Scholey. Their work appears in journals such as Blood, Nature, Genome, Journal of Experimental Zoology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.